Original drug products approved by the Food and Drug Administration (Center for Drug Evaluation and Research) in 2025

The annual review of new drugs approved by the FDA is an important tool for analyzing current trends in pharmacology and medicine, reflecting progress in the treatment of complex diseases, including oncological pathologies, orphan diseases, and infectious processes. The article aims to inform medica...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	D. V. Kurkin, N. A. Osadchenko, D. A. Galkina, D. A. Bakulin, Yu. G. Ustyakina, S. A. Voskresensky, A. R. Makarova, O. V. Shatalova, A. V. Strygin, V. I. Petrov, O. V. Marincheva, Yu. V. Gorbunova, K. N. Koryanova, E. S. Mishchenko, I. Sh. Gadaev, L. I. Shcherbakova, I. N. Dyakova, E. I. Morkovin, A. S. Shuvaeva
פורמט:	Artigo
שפה:	Russo
יצא לאור:	Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2026-06-01
סדרה:	Фармация и фармакология (Пятигорск)
נושאים:	fda оригинальные препараты иммунотерапия малые молекулы биопрепараты препараты для лечения орфанных болезней
גישה מקוונת:	https://www.pharmpharm.ru/jour/article/view/1895
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!